L. Niskanen et al., CAROTID-ARTERY INTIMA-MEDIA THICKNESS IN ELDERLY PATIENTS WITH NIDDM AND IN NONDIABETIC SUBJECTS, Stroke, 27(11), 1996, pp. 1986-1992
Background and Purpose The risk of atherosclerotic vascular disease is
increased both in subjects with non-insulin-dependent diabetes mellit
us (NIDDM) and in those with impaired glucose tolerance compared with
nondiabetic subjects. Although classic cardiovascular risk factors are
operative in subjects with NIDDM, other factors closely related to in
sulin resistance syndrome such as diabetic dyslipidemia and hyperglyce
mia itself may contribute to an excessive cardiovascular disease risk
in subjects with NIDDM. The purpose of this study was to investigate t
he carotid intimal-medial thicknesses (IMTs) and their determinants in
elderly patients with NIDDM and in control subjects. Methods We inves
tigated the common carotid and carotid bifurcation IMTs and their dete
rminants in groups Of elderly patients (n = 84, age 67.2 +/- 0.6 years
) with NIDDM and in 119 con control subjects (21 with impaired and 98
with normal glucose tolerance; ages 67.5 +/- 1.0 and 65.1 +/- 0.6 year
s, respectively). Results Common carotid and carotid bifurcation IMTs
were greater in the NIDDM group than in control subjects (P < .05 to .
01). In NIDDM patients, the mean carotid IMT con elated with postgluco
se 1-hour plasma insulin (r = .305, P = .01, adjusted for age and sex)
, serum LDL triglyceride (r = .237, P < .05, and apolipoprotein B conc
entrations (r = .263, P < .05). Fasting plasma immunoreactive insulin,
proinsulin, or specific insulin levels were not significantly associa
ted with carotid IMT. Both diabetic status (P < .05) and the presence
of clinical macrovascular disease (P < .01) contributed independently
to carotid IMT. Conclusions Carotid IMT was greater in NIDDM patients
than in control subjects, The main determinants of IMT in NIDDM patien
ts were related to both postglucose insulin levels and abnormal lipopr
otein profiles characteristic of NIDDM and insulin resistance syndrome
. Treatment of these factors is likely to reduce the atherosclerotic b
urden in NIDDM.